FineMark National Bank & Trust’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-3,336
| Closed | -$421K | – | 341 |
|
|
2018
Q2 | $421K | Buy |
3,336
+72
| +2% | +$9.09K | 0.03% | 276 |
|
|
2018
Q1 | $353K | Sell |
3,264
-32
| -1% | -$3.46K | 0.02% | 284 |
|
|
2017
Q4 | $361K | Sell |
3,296
-64
| -2% | -$7.01K | 0.02% | 270 |
|
|
2017
Q3 | $332K | Sell |
3,360
-574
| -15% | -$56.7K | 0.02% | 281 |
|
|
2017
Q2 | $398K | Sell |
3,934
-122
| -3% | -$12.3K | 0.03% | 252 |
|
|
2017
Q1 | $469K | Sell |
4,056
-641
| -14% | -$74.1K | 0.03% | 230 |
|
|
2016
Q4 | $564K | Sell |
4,697
-212
| -4% | -$25.5K | 0.05% | 200 |
|
|
2016
Q3 | $551K | Sell |
4,909
-248
| -5% | -$27.8K | 0.06% | 202 |
|
|
2016
Q2 | $639K | Sell |
5,157
-413
| -7% | -$51.2K | 0.07% | 184 |
|
|
2016
Q1 | $627K | Sell |
5,570
-533
| -9% | -$60K | 0.07% | 178 |
|
|
2015
Q4 | $663K | Buy |
6,103
+146
| +2% | +$15.9K | 0.08% | 173 |
|
|
2015
Q3 | $595K | Buy |
5,957
+484
| +9% | +$48.3K | 0.08% | 185 |
|
|
2015
Q2 | $625K | Sell |
5,473
-73
| -1% | -$8.34K | 0.08% | 192 |
|
|
2015
Q1 | $579K | Buy |
5,546
+2,567
| +86% | +$268K | 0.08% | 199 |
|
|
2014
Q4 | $359K | Buy |
2,979
+2,369
| +388% | +$285K | 0.05% | 251 |
|
|
2014
Q3 | $89K | Buy |
610
+463
| +315% | +$67.6K | 0.01% | 504 |
|
|
2014
Q2 | $25K | Buy |
+147
| New | +$25K | ﹤0.01% | 838 |
|
|
2013
Q3 | – | Sell |
-10
| Closed | -$2K | – | 1535 |
|
|
2013
Q2 | $2K | Buy |
+10
| New | +$2K | ﹤0.01% | 1246 |
|